ARCHIVES

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

FDA Recruiting ODAC Consumer Rep Candidates

March 31, 1995

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

Army Plans Solicitation For Breast Cancer Research Proposals

April 21, 1995

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013